Windlas Biotech Ltd (WINDLAS) — Announcement | 25 September 2026
Windlas Biotech announced that its trading window will close on October 1, 2026, ahead of the release of unaudited quarterly results for the September 30, 2026 quarter, to comply with regulatory disclosure rules.
About Windlas Biotech Ltd (WINDLAS)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when WINDLAS files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track WINDLAS — Free💡 Ask AI about this filing
📊 More WINDLAS filings
- 🔴 Announcement — 1 September 2026Windlas Biotech announced its schedule for virtual investor and analyst meetings on September 7, 202...
- Announcement — 11 August 2026Windlas Biotech announced that the audio recording of its investor conference call discussing unaudi...
- Announcement — 10 August 2026Windlas Biotech reported 18% YoY revenue growth to Rs 248 crore in Q1 FY27, driven by 84% contributi...
- 🟡 Board Meeting — 10 August 2026Windlas Biotech's board approved unaudited Q1 FY26 results showing revenue of **₹2,532.12 crores**, ...
- 🔴 Financial Results — 10 August 2026Windlas Biotech Limited reported record Q1 FY27 revenue of **₹248 crores**, up 18% YoY, driven by st...
🔥 Also filed on 25 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when WINDLAS files new disclosures
Track WINDLAS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track WINDLAS — FreeFree account · 2 AI queries/day